StreetAlpha.app
Home › Stocks › INO

Inovio Pharmaceuticals, Inc. (INO)

Healthcare
Members
LATEST PRICE

INOVIO develops DNA medicines and CELLECTRA delivery devices for diseases linked to HPV, cancer and infectious diseases. INO reports earnings on Tue, Nov 10, 2026.

Prices, price targets and earnings estimates for INO are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plans
AI Auto Pilots
Is INO in one of our four AI portfolios? Sign in free to see
See how it works→ Details ↓

Earnings

Earnings calendar →
Next report
Nov 10
2026 · Time not announced
Consensus EPS forecast
Members
EPS and revenue estimates
Year-ago EPS
Members
Same quarter last year
Options-implied move
Members
Move priced in by options
Analyst consensus
2 Buy
2 firms · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
2 Buy
2firms
2 Buy0 Hold0 Sell
Only 2 firms rated INO in the past 90 days, not enough for a consensus
Average 12-month target
Price targets for INOThe average, highest and lowest analyst targets and the target chart are shown to AI Starter and AI Pro members.See plans
Latest rating changes
JefferiesUpgrade
Aug 13Buy
Piper SandlerReiterated
Aug 3Buy
HC Wainwright & Co.Maintained
Jun 1Hold
DateFirmActionRatingPrice target
Aug 13JefferiesUpgradeBuy
Aug 3Piper SandlerReiteratedBuy
Jun 1HC Wainwright & Co.MaintainedHold
Loading…

Whale Options Flow

90D

No whale options trades in INO in the last 90 days.

Loading…

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether INO is in one of them and how their past INO trades turned out.

See how it works→ View all auto pilots→
INO in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered INO in an article yet. Here's the latest on the wider market.

macronewsFriday, October 30, 2026
Binance and Polymarket Hacks Test Crypto's Plumbing, Not Yet Macro
Binance paused withdrawals after a suspected theft of roughly $6 billion, while Polymarket halted trading for an hour after a vendor breach.
Jean Westart · 3 min read
macronewsMonday, October 26, 2026
S&P 500 Sits 2.5% Below Its Record Ahead of the Fed and Big Tech
The S&P 500 slipped 0.47% to 7,623.68, 2.5% below its record, as the Fed meets October 28 and Alphabet, Microsoft and Amazon report.
Marie Crown · 3 min read
macronewsMonday, October 26, 2026
Hightower's Stephanie Link Tells Investors to Add on Volatility
Hightower's Stephanie Link told CNBC's Squawk Box that investors should use market volatility to add to portfolios as earnings season unfolds.
Adam Landser · 2 min read

INO Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Nov 6
Who traded INO · since 2020
Christopher JacobsR · NY · 1 trade
Latest 1 filing
Christopher JacobsSell
$1K – $15KTraded Sep 8, 2020Filed Nov 6, 2020
PersonTypeAmountTradedFiledDelay
Christopher JacobsR · NYSell$1K – $15KSep 8, 2020Nov 6, 202059 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Inovio Pharmaceuticals

INOVIO is a biotechnology company based in Plymouth Meeting, Pennsylvania. It develops DNA medicines meant to help treat and prevent diseases linked to human papillomavirus (HPV), certain cancers and infectious diseases. Its lead candidate, INO-3107, is being studied for recurrent respiratory papillomatosis, a rare condition that causes tumors in the airway. The company also develops CELLECTRA devices that deliver these medicines into the body's cells. Its intended customers are patients and the healthcare providers who treat them.

Headquarters
Plymouth Meeting, PA
Founded
1983
Summary based on the company’s 2026 annual report (10-K) ↗